Lifetree Clinical Research

Trend shifts away from phase I ‘healthy volunteers’

Monday, May 16, 2011

Looking to stretch their research dollars beyond phase I safety determination and catch early glimpses of efficacy, sponsors and CROs are pursuing patient populations to provide those first signs, rather than depending on “healthy volunteers” for safety and then launching phase II trials.

[Read More]